Medical Engineered Materials Market Players:
- Evonik Industries AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Covestro AG
- BASF SE
- Solvay
- SABIC
- Trelleborg AB
- DSM
- Celanese Corporation
- DuPont de Nemours Inc
The global medical engineered materials market is dominated by several prominent players who lead in development and supply of high-performances materials for medical applications. These companies are focused on developing advanced bioresorbable materials used in medical devices. Their dominance is majorly driven by strong R&D activities, innovations, and strategic partnerships to meet the demand for lightweight and durable materials in healthcare. Some of the key companies in the market are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of medical engineered materials is evaluated at USD 31.21 billion.
The global medical engineered materials market size was worth over USD 27.87 billion in 2025 and is poised to witness a CAGR of around 13.3%, crossing USD 97.15 billion revenue by 2035.
North America’s medical engineered materials market will account for 37.2% share by 2035, driven by well-developed healthcare infrastructure and growing medical and pharmaceutical industries.
Key players in the market include Evonik Industries AG, Covestro AG, BASF SE, DSM Biomedical, Celanese Corporation, DuPont de Nemours, Inc., Solvay S.A., SABIC, Victrex plc, Arkema S.A.
